Marketing analysis of the market of antibacterial drugs for treatment of acute simple bronchitis in infants
Journal Title: Фармацевтичний журнал - Year 2016, Vol 5, Issue 5
Abstract
Particular concern among pediatricians and health professionals is caused by fairly high levels of morbidity acute simple bronchitis, especially in infants. An important issue of the pharmacotherapy is ensuring patients of sufficient number of effective and affordable drugs for the treatment of this nosology. Therefore, the aim of the work was the study of the assortment of antibacterial drugs for the treatment of acute simple bronchitis in children up to 3 years in the pharmaceutical market of Ukraine. Analytical, comparative, marketing, graphical methods of analysis, and the method of descriptive and abstract modeling and synthesis were used in the study. The analysis of the State Register of medicines, according to which established that as of May 2016 in the market of Ukraine registered 237 trade names of antibacterial drugs for the treatment of acute bronchitis in children, was conducted. Among them, the largest share falls on subgroups’ drugs of ceftriaxone (27.43%), cefuroxime (18.14%), ceftazidime (10.97%) and cefotaxime (10.13%). Results of the analysis show that the domestic market of antibacterial drugs is fairly saturated mainly due to foreign-made drugs, whose share in the overall structure of the investigated range is nearly 70.00%. It was found that the antibacterial drugs was introduced in the market by 23 producing countries, and the leading are drugs the production of India, which are presented in 7 subgroups of the general number of 52 names, and Ukraine are represented in the 10 subgroups in the amount of 72 names. The analysis found that the antibacterial drugs are present in the Ukrainian market by four dosage forms among which are leading parenteral release form. However, a significant number of drugs, particularly subgroups cefoperazone, ceftriaxone, ceftazidime, cefotaxime, cefazolin have no analogs in the available children's dosage forms, which negatively affects the effectiveness of treatment of such patients.
Authors and Affiliations
A. A. Kotvitska, E. S. Korobova
Keywords
Related Articles
- EP ID EP565569
- DOI -
- Views 41
- Downloads 0
Synthesis of new potential biological active substances among 3-mercapto-4-amino-5-benzyl-1,2,4-triazol-4H derivatives
Conventional approaches to the formation of 1,2,4-triazole ring allow to introduce different substituents into the heterocyclic ring during the synthesis of key intermediates stage. In continuation of previous studies th...
Quantitative determination of the content of phenolic compounds in a gel with the propolis phenolic hydrophobic drug and azelaic acid
Recently there has been an increased interest in creation of medicines based on apiculture products. It is known that the composition of the standardized substance of the propolis phenolic hydrophobic drug contains flavo...
Expert opinion piloting of statе regulation of prices for medicines hypertensive patients regional pharmaceutical market Lugansk region
According to the Ministry of Health of Ukraine Lugansk region has been recognized as the best region as a result of the implementation of the Pilot Project on state regulation of prices of medicines to patients GB. The...
Technology administration active substance in the ointment base
The problem of expanding the range of medicines that are used for the topical treatment of wound process, remains an important challenge for practical military medicine. In this aspect, there are topical ointments combin...
Determination of the cost-effective advantages of regimens of diabetes mellitus type 2 with modern DPP-4 inhibitors
Diabetes mellitus is a medical and social problem. The results of the pharmacoeconomical researches should be considered when choosing a rational pharmacotherapy. The purpose of this research of treatment regimens of di...